Antonio Montinaro

Summary

Affiliation: University Campus Bio-Medico
Country: Italy

Publications

  1. ncbi Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease
    G Di Sciascio
    Cattedra di Cardiologia, Libera Università, Roma
    Cardiologia 44:333-9. 1999
  2. doi Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) ra
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Via Alvaro del Portillo 200, Rome, Italy
    J Am Coll Cardiol 56:550-7. 2010
  3. doi Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy
    Eur Heart J 31:1337-43. 2010
  4. doi Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Rome, Italy
    J Am Coll Cardiol 54:558-65. 2009
  5. doi Percutaneous coronary interventions and statins therapy
    Annunziata Nusca
    Ther Adv Cardiovasc Dis 2:101-7. 2008
  6. ncbi [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences]
    Giuseppe Patti
    Dipartimento di Scienze Cardiovascolari, Università Campus Bio Medico, Roma
    Recenti Prog Med 96:499-507. 2005
  7. ncbi Early and long-term results of stenting of diffuse coronary artery disease
    G Di Sciascio
    Department of Cardiovascular Sciences, Campus Biomedico University, Rome, Italy
    Am J Cardiol 86:1166-70. 2000
  8. ncbi Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    Catheter Cardiovasc Interv 59:429-33. 2003
  9. doi Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    J Cardiovasc Med (Hagerstown) 12:151-6. 2011
  10. doi Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during an
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    Am J Cardiol 108:1-7. 2011

Collaborators

Detail Information

Publications16

  1. ncbi Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease
    G Di Sciascio
    Cattedra di Cardiologia, Libera Università, Roma
    Cardiologia 44:333-9. 1999
    ....
  2. doi Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) ra
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Via Alvaro del Portillo 200, Rome, Italy
    J Am Coll Cardiol 56:550-7. 2010
    ..This study sought to evaluate safety and effectiveness of in-laboratory (in-lab) 600-mg clopidogrel loading pre-percutaneous coronary intervention (PCI) versus routine 6-h pre-load...
  3. doi Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy
    Eur Heart J 31:1337-43. 2010
    ..To evaluate safety and effectiveness of clopidogrel reloading in patients on chronic clopidogrel therapy undergoing percutaneous coronary intervention (PCI)...
  4. doi Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Rome, Italy
    J Am Coll Cardiol 54:558-65. 2009
    ..This study was designed to investigate whether an acute atorvastatin reload before percutaneous coronary intervention (PCI) protects patients receiving chronic statin therapy from periprocedural myocardial damage...
  5. doi Percutaneous coronary interventions and statins therapy
    Annunziata Nusca
    Ther Adv Cardiovasc Dis 2:101-7. 2008
    ..Furthermore, patients receiving statins at the time of procedure show a significantly reduced incidence of contrast-induced nephropathy. All this evidence may strongly influence the clinical practice of an interventional cardiologist...
  6. ncbi [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences]
    Giuseppe Patti
    Dipartimento di Scienze Cardiovascolari, Università Campus Bio Medico, Roma
    Recenti Prog Med 96:499-507. 2005
    ..Endothelial dysfunction is actually considered a reversible phenomenon; drug therapies with ACE-inhibitors, angiotensin receptor blockers, statins, antioxidants agents have shown a beneficial effect on endothelial function...
  7. ncbi Early and long-term results of stenting of diffuse coronary artery disease
    G Di Sciascio
    Department of Cardiovascular Sciences, Campus Biomedico University, Rome, Italy
    Am J Cardiol 86:1166-70. 2000
    ..Thus, selected patients with diffuse CAD may be treated with satisfactory acute and long-term results by stent implantation...
  8. ncbi Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population
    Germano Di Sciascio
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    Catheter Cardiovasc Interv 59:429-33. 2003
    ..Whether coronary stenting may be a therapeutic strategy equivalent to surgery in selected patients needs to be investigated in prospective randomized trials...
  9. doi Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    J Cardiovasc Med (Hagerstown) 12:151-6. 2011
    ..300 mg clopidogrel loading dose. ARMYDA-2 SELECT is a prospectively planned subanalysis to investigate the effects of those different loading regimens on P-selectin levels...
  10. doi Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during an
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    Am J Cardiol 108:1-7. 2011
    ..These results lend further support to early use of high-dose statins as adjuvant pharmacologic therapy before percutaneous coronary revascularization...
  11. ncbi Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    J Am Coll Cardiol 49:1272-8. 2007
    ..This study sought to investigate potential protective effects of atorvastatin in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI)...
  12. doi Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELO
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University of Rome, Rome, Italy
    Am J Cardiol 112:162-8. 2013
    ..These data might be relevant in clinical practice, given the large number of patients with ACS who are still currently treated with clopidogrel during PCI. ..
  13. doi Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Hepa
    Giuseppe Patti
    Campus Bio Medico University of Rome, Rome, Italy
    Am J Cardiol 110:478-84. 2012
    ....
  14. ncbi Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty)
    Giuseppe Patti
    Department of Cardiovascular Sciences, Campus Bio Medico University, Rome, Italy
    Circulation 111:2099-106. 2005
    ..Although observational data have suggested that pretreatment with a high loading dose of clopidogrel may be more effective than a conventional dose, this hypothesis has never been tested in a randomized trial...
  15. doi Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures
    Alessandro Sciahbasi
    U O Cardiologia, Policlinico Casilino, ASL RmB, Rome, Italy
    Int J Cardiol 137:199-205. 2009
    ..Aim was to evaluate complications and discomfort associated with percutaneous coronary procedures employing RA or VCDs...
  16. ncbi Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions
    F Prati
    San Giovanni Hospital, Rome, Italy
    Eur Heart J 24:329-36. 2003
    ..The aim of this study was to define the impact of transversal lesion distribution on vessel remodelling in proximal and distal coronary segments using a 3D intravascular ultrasound (IVUS) reconstruction...